Catalio Capital Management

Catalio Capital Management is a life sciences investment firm that focuses on breakthrough biomedical technology companies.

money road map

Biotech

Alentis raises $181M series D to bring ADCs to the clinic

Swiss biotech Alentis Therapeutics has secured $181 million, money that will be used to launch clinical trials for two ADCs.

Gabrielle Masson Nov 12, 2024 7:00am

gold gold bracelet

Third Rock, Novo Holdings-backed Clasp hooks $150M series A

Mar 20, 2024 7:00am

maps navigate compass

Cartography gets on the map with $57M for immunotherapies

Jul 19, 2022 10:00am

Parachute

Alchemab CEO resigns citing 'personal reasons'—Chutes & Ladders

May 27, 2022 9:30am

Role of hundred dollar bills on other bills

Catalio reloads with $381M after financing Octant, Pheast

May 4, 2022 9:21am